Inhaled corticosteroids (ICSs) are indicated for the prevention of exacerbations in COPD;
however, a significant proportion of patients at low risk of exacerbations are treated with …

Comorbidities such as cardiac disease, diabetes mellitus, hypertension, osteoporosis, and
psychological disorders are commonly reported in patients with chronic obstructive …

We hypothesized that in patients with chronic obstructive pulmonary disease, loss of fat-free
mass (FFM) and loss of bone mineral density (BMD) were related to (1) each other and may …

Background Osteoporosis is common in patients with COPD, but its prevalence and
progression are not well characterized. Concerns have been raised over the possible …

While the pharmacological management of chronic obstructive pulmonary disease (COPD)
has evolved from the drugs used to treat asthma, the treatment models are different and the …

Обзоры вания заболевания (т. е. снижения показателя объе ма форсированного
выдоха за 1 ю с—ОФВ1). Точные механизмы системного воспаления при ХОБЛ …

Chronic obstructive pulmonary disease (COPD) is a respiratory disease that results in
airflow limitation and respiratory distress. The effects of COPD, however, are not exclusively …

Chronic obstructive pulmonary disease (COPD) is characterized by chronic inflammation in
both the airways causing airway obstruction and the lung tissues causing emphysema. The …

Background Osteoporosis is one of the important systemic features of COPD. Although
COPD itself is regarded as one risk factor for osteoporosis, the relationship between the …

PURPOSE We wanted to review systematically the efficacy, effectiveness, and safety of
inhaled corticosteroids with respect to health outcomes in patients with chronic obstructive …